1Csernansky JG.Treatment of schizohrenia:preventing the progression of disease.Psychiatr Clin North Am,2003,26(2):367-379
2Emsley R,Osthuizen P.The new and evolving pharmacotherapy of schizophrenia.Psychiat Clin North Am,2003,26(1):141-163
3Laloude P.Evaluating antipsychotic medications:predictors of clinical effectiveness.Can J Psychiat,2003,48(suppl,3):4-12
4Stimmel GL,Gutierrez MA,Lee V.Ziprasidone:an atypical antipsychotic drug for the treatment of schizophrenia.Clinical Therapeutics,2002,24(1):21-37
5Moller H,Nasrallah HA.Treatment of bipolar disorder.J clin Psychiatry,2003,64(Suppl,6):6-17
6Green AI,Canuso CM,Brenner MJ,et al.Detection and management of comorbidity in patients with schizophrenia.Psychiat Clin North Am,2003,26(1):115-139
7Wirshing DA,Pierre JM,Erhart SM,et al.Understanding the new and evolving profile of adverse drug effects in schizophrenia.Psychiat Clin North Am,2003,26(1):165-190
8Bourgeois JA,Mundh H.Priapism associated with risperidone:a case report.J Clin Psychiatry,2003,64(2):218-219
9Kaye NS.Ziprasidone augmentation of clozapine in patients.J Clin Psychiatry,2003,64(2):215-216
